VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- Telecure Technologies Inc. (CSE: TELE) (FSE: 6MZ) (the “Company” or “Telecure”) today confirmed that it is aware of a spurious and defamatory campaign launched against the Company, its principals, and several others, including service providers to the Company.
The Company notes that the launch of this most recent attack closely followed the dismissal of a lawsuit filed against it by certain former directors and officers of the Company. The U.S. Federal Court dismissed that lawsuit without a hearing. This most recent attack also follows the Company’s announcement that it has discovered that approximately US$500,000 was misappropriated from MyApps’ (a wholly owned subsidiary of Telecure) U.S. bank account after the Company’s CFO was inappropriately removed as a signing authority. The investigation into the missing funds is continuing.
Said Josh Rosenberg, CEO & Chairman of the Board of Directors of Telecure:
“We are learning a great deal about those who were previously involved with MyApps and as we continue to gather clear evidence, we will take the appropriate actions to put an end to this campaign of lies and innuendo. Those involved in and supportive of this campaign will pay a high price for their misconduct.
These are outrageous attacks with absolutely no basis in fact, and which betray a fundamental lack of respect and appreciation for Canadian and U.S. law. These latest false allegations, once more offered under the guise of anonymity, have besmirched the reputations of many people who have been involved in Telecure. We will not stand for our reputations to be taken hostage, and will defend the integrity of the Company, its principals, and those whose advice and guidance we seek. Just as our attackers have been resoundingly dismissed at every instance in the courts, we will continue to bring the full weight of the law on those who are involved in this latest unfounded campaign.”
About Telecure Technologies Inc.
Telecure is a U.S. focused health IT company that specializes in using technology to make healthcare more accessible and efficient. Telecure offers customized solutions for telemedicine needs. Through an acquisition strategy and unique customization capabilities, Telecure is focused on advancing its patient and user base. The Company provides a complete telemedicine solution via its platforms CallingDr™ and FindingDr™.
Contact
Investor Relations
Phone: 604-398-3432
Email: invest@telecuretech.com
Website: www.telecuretech.com
Forward-Looking Statements
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business and future of the Company’s business and plans. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward- looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported.
The Canadian Securities Exchange (CSE) has not reviewed, approved or disapproved the contents of this news release.
